U.S. Oral Solid Dosage Cdmo Market Size & Outlook
Related Markets
U.S. oral solid dosage cdmo market highlights
- The U.S. oral solid dosage cdmo market generated a revenue of USD 11,619.6 million in 2024 and is expected to reach USD 19,597.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 6% from 2025 to 2033.
- In terms of segment, tablets was the largest revenue generating product in 2024.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage cdmo market data book summary
| Market revenue in 2024 | USD 11,619.6 million |
| Market revenue in 2033 | USD 19,597.3 million |
| Growth rate | 6% (CAGR from 2025 to 2033) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules, Others Product |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Kuehne + Nagel International AG, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Siegfried Holding AG, AbbVie Inc, Chemical Works of Gedeon Richter PLC, Jubilant Pharmova, Piramal Pharma Solutions, Recipharm, CordenPharma, Alcami, DPT Laboratories, SPI Pharma, Quotient Sciences, Rubicon Research, Almac Group, Aenova Group |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.6% of the global oral solid dosage cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. oral solid dosage cdmo market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,925.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage CDMO Market Scope
Oral Solid Dosage CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Rubicon Research | View profile | 251-500 | Mumbai, Maharashtra, India, Asia | http://www.rubicon.co.in/ |
| SPI Pharma | View profile | 251-500 | Wilmington, Delaware, United States, North America | http://spipharma.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Quotient Sciences | View profile | 251-500 | Nottingham, Nottingham, United Kingdom, Europe | https://www.quotientsciences.com/ |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Chemical Works of Gedeon Richter PLC | View profile | 11901 | Gyomroi ut 19-21, Budapest, Hungary, 1103 | https://www.gedeonrichter.com/hu-hu |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Kuehne + Nagel International AG | View profile | 93064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | http://www.kuehne-nagel.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
U.S. oral solid dosage cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage cdmo market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 34.9% in 2024. Horizon Databook has segmented the U.S. oral solid dosage cdmo market based on tablets, capsules, powders, granules, others product covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. holds the highest share of 91.82% in the global oral solid dosage CDMO market due to major expansion activities of globally dominant players in the country.
Increasing R&D investments, growing drug development costs, expensive raw ingredients, and a rising need for oral solid dosage products are driving numerous pharmaceutical entities in the U.S. to outsource key aspects of the drug development process.
Moreover, U.S.-based pharmaceutical contract manufacturing companies have local and international clients, aiding revenue generation in this country. A robust and wellestablished supply chain of local & international players in the country is a crucial factor likely to propel the oral solid dosage CDMO market in the U.S.
Reasons to subscribe to U.S. oral solid dosage cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. oral solid dosage cdmo market databook
-
Our clientele includes a mix of oral solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. oral solid dosage cdmo market , including forecasts for subscribers. This country databook contains high-level insights into U.S. oral solid dosage cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. oral solid dosage cdmo market size, by product, 2021-2033 (US$M)
U.S. Oral Solid Dosage CDMO Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
